My NCBI | Sign In
RSS Settings
  • Search: Triplitt C[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.

    Cervera A, Wajcberg E, Sriwijitkamol A, Fernandez M, Zuo P, Triplitt C, Musi N, DeFronzo RA, Cersosimo E.

    Am J Physiol Endocrinol Metab. 2008 May;294(5):E846-52. Epub 2008 Mar 11.PMID: 18334612 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes.

    Triplitt C, McGill JB, Porte D Jr, Conner CS.

    J Manag Care Pharm. 2007 Dec;13(9 Suppl C):S2-16; quiz S17. Review.PMID: 18062735 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Physiological and molecular determinants of insulin action in the baboon.

    Chavez AO, Lopez-Alvarenga JC, Tejero ME, Triplitt C, Bastarrachea RA, Sriwijitkamol A, Tantiwong P, Voruganti VS, Musi N, Comuzzie AG, DeFronzo RA, Folli F.

    Diabetes. 2008 Apr;57(4):899-908. Epub 2008 Jan 3.PMID: 18174524 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.

    Fernandez M, Triplitt C, Wajcberg E, Sriwijilkamol AA, Musi N, Cusi K, DeFronzo R, Cersosimo E.

    Diabetes Care. 2008 Jan;31(1):121-7. Epub 2007 Oct 1.PMID: 17909084 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Rosiglitazone decreases albuminuria in type 2 diabetic patients.

    Miyazaki Y, Cersosimo E, Triplitt C, DeFronzo RA.

    Kidney Int. 2007 Dec;72(11):1367-73. Epub 2007 Sep 5.PMID: 17805239 [PubMed - indexed for MEDLINE]Related articles

    6.

    New technologies and therapies in the management of diabetes.

    Triplitt CL.

    Am J Manag Care. 2007 Apr;13 Suppl 2:S47-54. Review.PMID: 17417933 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    First approved inhaled insulin therapy for diabetes mellitus.

    Jani R, Triplitt C, Reasner C, Defronzo RA.

    Expert Opin Drug Deliv. 2007 Jan;4(1):63-76. Review. Erratum in: Expert Opin Drug Deliv. 2007 Mar;4(2):191. PMID: 17184163 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.

    Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA.

    Diabetes Care. 2006 Nov;29(11):2371-7.PMID: 17065670 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    What are incretins, and how will they influence the management of type 2 diabetes?

    Blonde L, Rosenstock J, Triplitt C.

    J Manag Care Pharm. 2006 Sep;12(7 Suppl A):S2-12; quiz S14-6.PMID: 16981805 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Exenatide: from the Gila monster to the pharmacy.

    Triplitt C, Chiquette E.

    J Am Pharm Assoc (2003). 2006 Jan-Feb;46(1):44-52; quiz 53-5. Review.PMID: 16529340 [PubMed - indexed for MEDLINE]Related articles

    11.

    Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus.

    Triplitt C, Wright A, Chiquette E.

    Pharmacotherapy. 2006 Mar;26(3):360-74. Review.PMID: 16503716 [PubMed - indexed for MEDLINE]Related articles

    12.

    Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects.

    Wajcberg E, Miyazaki Y, Triplitt C, Cersosimo E, DeFronzo RA.

    Diabetes Care. 2004 Dec;27(12):2868-73.PMID: 15562199 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

    Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43.PMID: 12424102 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.

    Miyazaki Y, Glass L, Triplitt C, Matsuda M, Cusi K, Mahankali A, Mahankali S, Mandarino LJ, DeFronzo RA.

    Diabetologia. 2001 Dec;44(12):2210-9.PMID: 11793023 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...